{"id":43369,"date":"2023-11-20T03:26:03","date_gmt":"2023-11-20T09:26:03","guid":{"rendered":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/qin-sarcoma-pub\/"},"modified":"2023-11-20T03:26:03","modified_gmt":"2023-11-20T09:26:03","slug":"qin-sarcoma-pub","status":"publish","type":"tcia_citation","link":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/qin-sarcoma-pub\/","title":{"rendered":"QIN-SARCOMA-PUB"},"template":"","class_list":["post-43369","tcia_citation","type-tcia_citation","status-publish"],"tcia_citation_type":"Publication Citation","tcia_citation_text":"<p><span><span>Meyer, J. M., Perlewitz, K. S., Hayden, J. B., Doung, Y.-C., Hung, A. Y., Vetto, J. T., Pommier, R. F., Mansoor, A., Beckett, B. R., Tudorica, A., Mori, M., Holtorf, M. L., Afzal, A., Woodward, W. J., Rodler, E. T., Jones, R. L., Huang, W., &amp; Ryan, C. W. (2013). <strong>Phase I Trial of Preoperative Chemoradiation plus Sorafenib for High-Risk Extremity Soft Tissue Sarcomas with Dynamic Contrast-Enhanced MRI Correlates. <\/strong>In Clinical Cancer Research (Vol. 19, Issue 24, pp. 6902\u20136911). American Association for Cancer Research (AACR). <a href=\"https:\/\/doi.org\/10.1158\/1078-0432.ccr-13-1594\">https:\/\/doi.org\/10.1158\/1078-0432.ccr-13-1594<\/a> PMCID:<span>\u00a0<\/span><\/span><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/pmc3869565\/\">PMC3869565<\/a><\/span><\/p>\n","tcia_citation_statement":"","tcia_citation_doi":"10.1158\/1078-0432.ccr-13-1594","_links":{"self":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations\/43369","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations"}],"about":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/types\/tcia_citation"}],"wp:attachment":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/media?parent=43369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}